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Introduction {#s1}
============

Iodine is an essential trace element required for the normal thyroid hormone activity, specifically that of thyroxine and tri-iodothyronine. Both insufficient and excessive iodine intake can cause thyroid-hormone disorders [@pone.0109549-World1]--[@pone.0109549-Ozpinar1] and the presence of goiter and thyroid nodules (TNs) represents thyroid diseases. The term *goiter* describes the enlargement of the thyroid gland and the goiter prevalence of this condition is considered an important and sensitive long-term indicator of iodine intake [@pone.0109549-World1], [@pone.0109549-Delange1]. The prevalence of goiter in school-age children is related to the severity of iodine deficiency. For example, a prevalence of 0.0--4.9% suggests no iodine deficiency; 5.0--19.9% indicates mild deficiency; 20.0--29.9% reveals moderate deficiency; and severe deficiency is observed at ≥30% [@pone.0109549-World1]. Excessive iodine, however, can also lead to goiter [@pone.0109549-World1].

TNs are discrete structurally distinct lesions within the thyroid gland, separate from the surrounding parenchyma [@pone.0109549-Polyzos1]. Previous work indicates that the frequency of TNs vary considerably among the general population---4--7% are detected by palpation [@pone.0109549-Singer1], 20--76% are found with ultrasound [@pone.0109549-Mazzaferri1], [@pone.0109549-Tan1], and 19--67% are documented from autopsy data [@pone.0109549-Hull1]--[@pone.0109549-Oertel1]. Although most TNs are benign, cancer should be suspected with the presence of TNs [@pone.0109549-Polyzos1], [@pone.0109549-Gharib1], because 5--15% may be malignant (carcinomas) [@pone.0109549-American1]. Thus, goiter and TNs are common thyroid disorders with an intimate association with iodine intake.

China was once an iodine-deficient country; prior to the 1970s, 370 million people lived in iodine-deficient areas [@pone.0109549-Endemic1]. Iodine deficiencies manifested various ways, including goiter, cretinism, endemic mental retardation, and decreased fertility rates [@pone.0109549-World1], all of which are generally classified as iodine deficiency disorders (IDDs) [@pone.0109549-World1], [@pone.0109549-Luton1]. To reduce IDDs, in 1979, a program of local iodine fortification was introduced into these iodine-deficient areas; and in 1996, China launched the Universal Salt Iodization (USI) program [@pone.0109549-Ministry1]. Although the USI program reduced the prevalence of goiter, the median urinary iodine concentration (UIC) in school-age children simultaneously rose sharply---reaching 330 µg/L in 1997 and 306 µg/L in 1999. For this reason, in 2002, national standards for iodized salt were revised to reduce the iodine concentration at the production level [@pone.0109549-Delange1]. In 2012, global data identified China as a region with more than adequate iodine intake [@pone.0109549-Zimmermann2]. Meanwhile, since the implementation of the USI program, a growing number of Chinese clinical endocrinologists have reported an increasing incidence of thyroid diseases, especially in recent years [@pone.0109549-Zhou1]--[@pone.0109549-Wu1].

China has diverse environments with varied populations and socio-economic conditions, complicating unified epidemiological investigations for prevalence of goiter and TNs, most of which were limited to specific geographic areas or populations. Thus, data may not accurately represent these two diseases especially in light of the implementation of the USI program which may skew data for the epidemiology of goiter and TNs. Thus, to formulate appropriate local public health policies and criteria, we must document the epidemiology and distribution of both diseases and use the few previous studies to provide comprehensive analyses of detailed explorations and secular trends, geographic properties, and iodine status.

Here, we describe a systematic review and meta-analysis of the prevalence of goiter and TNs before and after implementation of the USI program in mainland China from 1985 to 2014.

Materials and Methods {#s2}
=====================

Search Strategy {#s2a}
---------------

Goiter and TNs are independent diseases and iodine intake in China changed markedly after 1996 after the implementation of USI. Therefore, we conducted three meta-analyses---one on the prevalence of goiter before 1996 and one after 1996 and one analysis of the prevalence of TNs. We searched all English-language reports of population-based studies on the prevalence of goiter and TNs using PubMed and Google Scholar, and searched all Chinese reports manually and on-line using the CNKI (Chinese National Knowledge Infrastructure), Chinese Wanfang and Chongqing VIP databases, from Jan 1985 to Feb 2014. Search key words were "goiter," "thyroid nodule(s)," "thyroid disorder(s)," "epidemiology" and "prevalence(s)". We also scanned relevant reference lists and reviews to find additional studies. Attempts were made to contact authors of the identified papers for necessary details not given in the original texts. The PRISMA guideline for systematic reviews and meta-analyses was followed closely [@pone.0109549-Liberati1], see [Checklist S1](#pone.0109549.s001){ref-type="supplementary-material"}.

Inclusion and Exclusion Criteria {#s2b}
--------------------------------

The following inclusion criteria were adopted for paper selection: (1) Data were acquired through population-based studies instead of hospital-based studies; (2) study participants were recruited from a random community-based sample, rather than from volunteers or those receiving routine-health examinations, and the subjects had to be living in mainland China; (3) the studies contained sufficient information to conduct pooled analysis of the prevalence; (4) if the same study data were reported in both English and Chinese, the English publication was included.

Studies were excluded if: (1) they were reviews or case reports; (2) the participants suffered from any related diseases or took medicines known to affect thyroid structure or function; (3) the study focused on participants with one underlying condition (such as pregnant women and smokers) or a certain occupation; (4) they were duplicate publications.

Data Extraction {#s2c}
---------------

The literature was searched independently by two reviewers. Any discrepancies between the extracted data of the two reviewers were reconciled through discussion. The literature-search process is shown in [Figure 1](#pone-0109549-g001){ref-type="fig"}. For all included studies, the first author\'s name, publication date, study year, age, location, sample size, events data and prevalence were recorded.

![Flow diagram of the literature-search process.](pone.0109549.g001){#pone-0109549-g001}

Iodine Status {#s2d}
-------------

Median UIC is recognized as the most practical biochemical marker for iodine nutrition [@pone.0109549-Zou1]. Using the criteria from WHO/UNICEF/ICCIDD [@pone.0109549-World1], the iodine status was identified based on the median UIC, where the median UIC ≤99 µg/L is insufficient, 100--199 µg/L is adequate, 200--299 µg/L is more than adequate and a median UIC ≥300 µg/L is considered to be excessive.

Statistical Analysis {#s2e}
--------------------

The pooled prevalence and 95% confidence intervals (CIs) were used to estimate the prevalence of goiter and TNs in mainland China. All meta-analyses were calculated for heterogeneity using the Chi-square based Q test and the I^2^ test (25, 50 and 75% were considered low, moderate and high levels of heterogeneity, respectively) [@pone.0109549-Higgins1]. For a moderate or high level of heterogeneity we adopted a random-effects meta-analysis rather than using a fixed-effects model. Addressing heterogeneity and performing a secondary analysis required subgroup analysis. Publication bias was estimated through Egger\'s test. A *p*-value less than 0.05 indicated statistical significance. Meta-analyses were carried out in Stata Version 11.0 (Stata Corp LP, TX). Differences in prevalence among different groups were analyzed using the Chi-square test with SPSS Version 17.0 (SPSS Software, Chicago, IL).

Results {#s3}
=======

Characteristics of Papers {#s3a}
-------------------------

[Figure 1](#pone-0109549-g001){ref-type="fig"} provides a schematic representation of the process for identifying, screening, and including studies in the review. The search strategy resulted in 31 articles (4 published in English and 27 in Chinese), reporting 52 studies---29 studies reporting goiter prevalence estimates (15 before 1996 and 14 after) and 23 on TNs. [Table 1](#pone-0109549-t001){ref-type="table"} provides a descriptive summary of these studies.

10.1371/journal.pone.0109549.t001

###### Characteristics of studies on the prevalence of goiter and TNs.

![](pone.0109549.t001){#pone-0109549-t001-1}

  First author                            Publication year               Area               Rural/Urban   Inland/Coastal   Study year   Sample size   Case    Prevalence (%)
  -------------------------------------- ------------------ ------------------------------ ------------- ---------------- ------------ ------------- ------- ----------------
  **Prevalence of goiter before 1996**                                                                                                                       
  Wang LF [@pone.0109549-Wang1]                 1992            Kunlun Plain, Xinjiang         Rural          Inland          1987         1236        629        50.89
  Wang LF [@pone.0109549-Wang1]                 1992            Kunlun Plain, Xinjiang         Rural          Inland          1987         3686       1223        33.18
  Wang LF [@pone.0109549-Wang1]                 1992            Kunlun Plain, Xinjiang         Rural          Inland          1987         2351        415        17.65
  Dou DX [@pone.0109549-Dou1]                   1992               Zhaoguan, Anhui             Rural          Inland          1986          398        71         17.84
  Chen HM [@pone.0109549-Chen1]                 2000                Puyang, Henan              Rural          Inland          1990         1589        336        21.15
  Zhang JL [@pone.0109549-Zhang1]               1992               Linyi, Shandong             Mixed          Inland          1985         48083      2324         4.83
  Zhang JL [@pone.0109549-Zhang1]               1992               Linyi, Shandong             Mixed          Inland          1989        110609      3445         3.11
  Wu WY [@pone.0109549-Wu2]                     2002              Qingyuan, Zhejiang           Rural          Inland          1985        154451      60434       39.13
  Zhang Z [@pone.0109549-Zhang2]                2002                Fuzhou, Fujian             Urban         Coastal          1989         10454       584         5.59
  Zhang Z [@pone.0109549-Zhang2]                2002               Wuyishan, Fujian            Urban          Inland          1989         1032        253        24.52
  Bao Y [@pone.0109549-Bao1]                    1994               Xuzhou, Jiangsu             Rural          Inland          1990         81548      16720       20.50
  Bao Y [@pone.0109549-Bao1]                    1994               Xuzhou, Jiangsu             Urban          Inland          1990         3999        732        18.30
  Su MY [@pone.0109549-Su1]                     1989               Tekesi, Xinjiang            Rural          Inland          1987          202        92         45.54
  Su MY [@pone.0109549-Su1]                     1989               Tekesi, Xinjiang            Rural          Inland          1987          220        54         24.55
  Zheng HB [@pone.0109549-Zheng1]               1988               Cangzhou, Hebei             Rural          Inland          1985         16324      2631        16.12
  **Prevalence of goiter after 1996**                                                                                                                        
  Yu J [@pone.0109549-Yu1]                      2004            Huachuan, Heilongjiang         Rural          Inland          2002          112        21         18.75
  Yu XH [@pone.0109549-Yu2]                     2008              Panshan, Liaoning            Rural          Inland          1999          815        189        23.19
  Yu XH [@pone.0109549-Yu2]                     2008              Zhangwu, Liaoning            Rural          Inland          1999         1514        256        16.91
  Yu XH [@pone.0109549-Yu2]                     2008               Huanghua, Hebei             Rural          Inland          1999         1056        80          7.58
  Zhao SH [@pone.0109549-Zhao1]                 2004               Yantai, Shandong            Rural         Coastal          2000          554        60         10.83
  Zhao SH [@pone.0109549-Zhao1]                 2004               Weihai, Shandong            Rural         Coastal          2000          543        54          9.94
  Zhao SH [@pone.0109549-Zhao1]                 2004               Weihai, Shandong            Rural         Coastal          2000          437        32          7.32
  Zhao SH [@pone.0109549-Zhao1]                 2004               Rizhao, Shandong            Rural         Coastal          2000          610        51          8.36
  Zhao SH [@pone.0109549-Zhao1]                 2004               Rizhao, Shandong            Rural         Coastal          2000          330        43         13.03
  Zhao SH [@pone.0109549-Zhao1]                 2004              Qingdao, Shandong            Rural         Coastal          2000          570        49          8.60
  Zhao SH [@pone.0109549-Zhao1]                 2004               Wulian, Shandong            Rural          Inland          2000          562        24          4.27
  Zhang Z [@pone.0109549-Zhang2]                2002                Fuzhou, Fujian             Urban         Coastal          1999         3473        272        7\. 83
  Zhang Z [@pone.0109549-Zhang2]                2002               Wuyishan, Fujian            Urban          Inland          1999         2394        277        11.57
  Zhu WY [@pone.0109549-Zhu1]                   2009              Zhoushan, Zhejiang           Mixed         Coastal          2007         1389        421        30.31
  **Prevalence of TNs**                                                                                                                                      
  Yu XH [@pone.0109549-Yu2]                     2008              Panshan, Liaoning            Rural          Inland          1999          815        103        12.64
  Yu XH [@pone.0109549-Yu2]                     2008              Zhangwu, Liaoning            Rural          Inland          1999         1514        154        10.17
  Yu XH [@pone.0109549-Yu2]                     2008               Huanghua, Hebei             Rural          Inland          1999         1056        114        10.80
  Chen ZX [@pone.0109549-Chen2]                 2013              Hangzhou, Zhejiang           Mixed          Inland          2010         9412       2822        29.98
  Lou XM [@pone.0109549-Lou1]                   2011            Daishan, etc, Zhejiang         Mixed         Coastal          2009          456        66         14.47
  Lou XM [@pone.0109549-Lou1]                   2011            Haining, etc, Zhejiang         Mixed         Coastal          2009          321        48         14.95
  Lou XM [@pone.0109549-Lou1]                   2011           Xiangshan, etc, Zhejiang        Mixed         Coastal          2009          280        59         21.07
  Feng SY [@pone.0109549-Feng1]                 2006         Gaochun and Chuzhou, Jiangsu      Rural          Inland          2005         2280        407        17.85
  Li SJ [@pone.0109549-Li1]                     2012              Fenghua, Zhejiang            Rural         Coastal          2010          781        160        20.49
  Chi HY [@pone.0109549-Chi1]                   2013               Weihai, Shandong            Urban         Coastal          2008         4405       1390        31.56
  Chen LD [@pone.0109549-Chen3]                 2011               Lishui, Zhejiang            Rural          Inland          2006          638        245        38.40
  Wang XD [@pone.0109549-Wang2]                 2008                Wuxi, Jiangsu              Urban          Inland          2005          750        169        22.53
  Liu F [@pone.0109549-Liu1]                    2012               Ruian, Zhejiang             Urban          Inland          2010         5060       1166        23.04
  Yang NZ [@pone.0109549-Yang2]                 2012              Taizhou, Zhejiang            Mixed          Inland          2010          793        182        22.95
  Liu ZY [@pone.0109549-Liu2]                   2012              Zhoushan, Zhejiang           Mixed         Coastal          2010         3206        926        28.88
  Zhu WY [@pone.0109549-Zhu2]                   2010              Zhoushan, Zhejiang           Mixed         Coastal          2006         3284        831        25.30
  Zou SR [@pone.0109549-Zou1]                   2012                   Shanghai                Mixed         Coastal          2009         7369       2011        27.29
  Guo HW [@pone.0109549-Guo1]                   2014               Nanjing, Jiangsu            Urban          Inland          2011         9533       4439        46.56
  Zhang JL [@pone.0109549-Zhang3]               2013               Yan\'an, Shanxi             Mixed          Inland          2012         2970        822        27.68
  Liu Y [@pone.0109549-Liu3]                    2012               Chengdu, Sichuan            Urban          Inland          2009         1500        255        17.00
  Yang YX [@pone.0109549-Yang3]                 2011               Guiyang, Guizhou            Urban          Inland          2009         1512        153        10.12
  Shen Y [@pone.0109549-Shen1]                  2013                   Shanghai                Mixed         Coastal          2010          695        159        22.88
  Zhang SG [@pone.0109549-Zhang4]               2010               Xuzhou, Jiangsu             Rural          Inland          2008          468        117        25.00

All studies were based on general population samples. Before 1996, 436,182 people met the inclusion criteria for goiter; the criteria for diagnosis were in line with those of WHO, which was based on palpations. Another 14,359 people met the criteria for goiter after 1996. Goiter diagnosis after 1996 was based on palpation or ultrasound. After a diagnose with ultrasound, 59,098 people met the inclusion criteria for TNs.

Pooled Prevalence of Goiter and TNs {#s3b}
-----------------------------------

As shown in [Figs 2](#pone-0109549-g002){ref-type="fig"} and [3](#pone-0109549-g003){ref-type="fig"}, the pooled prevalence of goiter before 1996 was 22.8% (95% CI: 15.3%, 30.3%), with the actual numbers ranging from 3.11 to 50.89%; after 1996, the pooled prevalence, 12.6% (95% CI: 9.4%, 15.8%) in the range of 4.27--30.31%, was significantly lower compared with the prevalence prior to 1996 (χ^2^ = 532.56, *p*\<0.001). [Figure 4](#pone-0109549-g004){ref-type="fig"} shows a pooled prevalence of 22.7% (95%CI: 18.3%, 27.0%) for TNs with individual studies ranging from 10.12--46.56%. Individual disease conditions of the provinces and municipalities are shown in the maps in [Figs 5](#pone-0109549-g005){ref-type="fig"}--[7](#pone-0109549-g007){ref-type="fig"}.

![Forest plot displaying the pooled goiter prevalence in mainland China before 1996.](pone.0109549.g002){#pone-0109549-g002}

![Forest plot displaying the pooled goiter prevalence in mainland China after 1996.](pone.0109549.g003){#pone-0109549-g003}

![Forest plot of the pooled prevalence of TNs in mainland China.](pone.0109549.g004){#pone-0109549-g004}

![Regional distribution of pooled goiter prevalence in mainland China before 1996.](pone.0109549.g005){#pone-0109549-g005}

![Regional distribution of pooled goiter prevalence in mainland China after 1996.](pone.0109549.g006){#pone-0109549-g006}

![Regional distribution of pooled prevalence of TNs in mainland China.](pone.0109549.g007){#pone-0109549-g007}

Subgroup Analysis {#s3c}
-----------------

Goiter prevalences before and after 1996 and TNs were analyzed in subgroups, divided by location (North, South, East, West and Central China) and the type of area (rural, urban and mixed), as shown in [Tables 2](#pone-0109549-t002){ref-type="table"}--[4](#pone-0109549-t004){ref-type="table"}.

10.1371/journal.pone.0109549.t002

###### Prevalence of goiter before 1996 in mainland China by different stratification factors.

![](pone.0109549.t002){#pone-0109549-t002-2}

  Subgroups             Prevalence % (95%CI)    No of studies   Heterogeneity   Case/Total   
  -------------------- ----------------------- --------------- --------------- ------------- ------------------
  **Area**                                                                                   
  Rural                   28.6 (20.7--36.5)          10             99.9          \<0.001       82605/262005
  Mixed                    4.0 (2.3--5.7)             2             99.6          \<0.001       5769/158692
  Urban                   16.1 (5.0--27.2)            3             99.6          \<0.001        1569/15485
  **Coastal/Inland**                                                                         
  Coastal                  5.6 (5.1--6.0)             1              \-             \-           584/10454
  Inland                  24.0 (16.0--32.1)          14             100.0         \<0.001       89359/425728
  **Altitude**                                                                               
  \<200                   13.4 (8.3--18.5)            8             100.0         \<0.001       26843/273004
  200--500                31.9 (17.6--46.2)           2             99.2          \<0.001       60687/155483
  500--1000                      \-                   0              \-             \-               \-
  \>1000                  34.3 (21.9--46.6)           5             99.2          \<0.001        2413/7695
  **Iodine Status**                                                                          
  Insufficient            25.5 (12.0--39.1)          10             100.0         \<0.001       67878/288418
  Adequate                14.5 (−4.8--33.8)           2             97.8          \<0.001        2378/48303
  More than Adequate             \-                   0              \-             \-               \-
  Excess                  19.2 (15.8--22.6)           3             98.9          \<0.001       19687/99461
  **Method**                                                                                 
  Palpation               22.8 (15.3--30.3)          15             100.0         \<0.001       89943/436182
  Ultrasound                     \-                   0              \-             \-               \-
  **Sample Size**                                                                            
  \<5000                  28.0 (21.3--34.8)           9             98.9          \<0.001        3805/14713
  \>5000                  14.9 (3.1--26.7)            6             100.0         \<0.001       86138/421469
  **Location**                                                                               
  North China             16.1 (15.6--16.7)           1              \-             \-           2631/16324
  South China             15.0 (−3.5--33.6)           2             99.5          \<0.001        837/11486
  East China              17.3 (4.8--29.8)            6             100.0         \<0.001       83726/399088
  West China              34.3 (21.9--46.6)           5             99.2          \<0.001        2413/7695
  Central China           21.1 (19.1--23.2)           1              \-             \-            336/1589
  **Total**             **22.8 (15.3--30.3)**      **15**         **100.0**     **\<0.001**   **89943/436182**

10.1371/journal.pone.0109549.t003

###### Prevalence of goiter after 1996 in mainland China by different stratification factors.
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  Subgroups             Prevalence % (95%CI)   No of studies   Heterogeneity   Case/Total   
  -------------------- ---------------------- --------------- --------------- ------------- ----------------
  **Area**                                                                                  
  Rural                   11.5 (8.3--14.6)          11             95.0          \<0.001        859/7103
  Mixed                  30.3 (27.9--32.7)           1              \-             \-           421/1389
  Urban                   9.7 (6.0--13.3)            2             95.5          \<0.001        549/5867
  **Coastal/Inland**                                                                        
  Coastal                 12.0 (7.1--16.9)           8             97.7          \<0.001        982/7906
  Inland                  13.4 (8.5--18.4)           6             97.4          \<0.001        847/6453
  **Altitude**                                                                              
  \<200                   13.4 (9.6--17.3)          12             97.5          \<0.001       1528/11403
  200--500                7.9 (0.8--15.1)            2             97.8          \<0.001        301/2956
  500--1000                      \-                  0              \-             \-              \-
  \>1000                         \-                  0              \-             \-              \-
  **Iodine Status**                                                                         
  Insufficient           23.2 (20.3--26.1)           1              \-             \-           189/815
  Adequate                 4.3 (2.6--5.9)            1              \-             \-            24/562
  More than Adequate      9.8 (6.3--13.3)            5             94.7          \<0.001        660/6604
  Excess                  14.5 (8.8--20.1)           7             97.7          \<0.001        956/6378
  **Method**                                                                                
  Palpation               9.7 (6.0--13.3)            2             95.5          \<0.001        549/5867
  Ultrasound              13.2 (8.8--17.5)          12             97.6          \<0.001       1280/8492
  **Sample Size**                                                                           
  \<5000                  12.6 (9.4--15.8)          14             97.4          \<0.001       1829/14359
  \>5000                         \-                  0              \-             \-              \-
  **Location**                                                                              
  North China             16.5 (8.9--24.0)           4             97.3          \<0.001        546/3497
  South China             9.7 (6.0--13.3)            2             95.5          \<0.001        549/5867
  East China              11.6 (5.9--17.3)           8             97.9          \<0.001        734/4995
  West China                     \-                  0              \-             \-              \-
  Central China                  \-                  0              \-             \-              \-
  **Study Year**                                                                            
  1996--2001              10.7 (8.3--13.1)          12             95.0          \<0.001       1387/12858
  2002--2014             25.1 (13.8--36.3)           2             88.7           0.003         442/1501
  **Total**             **12.6 (9.4--15.8)**      **14**         **97.4**      **\<0.001**   **1829/14359**

10.1371/journal.pone.0109549.t004

###### Prevalence of TNs in mainland China by different stratification factors.
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  Subgroups             Prevalence % (95%CI)    No of studies   Heterogeneity   Case/Total   
  -------------------- ----------------------- --------------- --------------- ------------- -----------------
  **Area**                                                                                   
  Rural                   19.1 (13.7--24.6)           7             97.7          \<0.001        1300/7552
  Mixed                   24.0 (21.6--26.4)          10             94.5          \<0.001       7926/28786
  Urban                   25.1 (13.2--37.1)           6             99.8          \<0.001       7572/22760
  **Coastal/Inland**                                                                         
  Coastal                 23.3 (20.2--26.4)           9             95.5          \<0.001       5650/20797
  Inland                  22.5 (15.7--29.2)          14             99.6          \<0.001       11148/38301
  **Altitude**                                                                               
  \<200                   23.4 (18.7--28.0)          20             99.3          \<0.001       15568/53116
  200--500                17.0 (15.1--18.9)           1              \-             \-           255/1500
  500--1000                      \-                   0              \-             \-              \-
  \>1000                  18.9 (1.7--36.1)            2             99.6            \-           975/4482
  **Sample Size**                                                                            
  \<5000                  20.7 (17.0--24.5)          19             98.4          \<0.001       6360/27724
  \>5000                  31.7 (21.8--41.7)           4             99.7          \<0.001       10438/31374
  **Location**                                                                               
  North China             11.0 (9.7--12.3)            3             35.9           0.210         371/3385
  South China                    \-                   0              \-             \-              \-
  East China              25.5 (21.2--29.8)          17             99.1          \<0.001       15197/49731
  West China              18.3 (7.6--28.9)            3             99.2          \<0.001        1230/5982
  Central China                  \-                   0              \-             \-              \-
  **Gender**                                                                                 
  Male                    16.6 (12.1--21.2)          23             99.0          \<0.001       5420/24469
  Rural                   11.1 (5.9--16.3)            7             97.3          \<0.001        302/2708
  Mixed                   19.2 (16.6--21.7)          10             90.4          \<0.001       2854/12865
  Urban                   19.2 (9.1--29.2)            6             99.3          \<0.001        2264/8896
  Female                  26.9 (22.2--31.6)          23             99.0          \<0.001       11378/34629
  Rural                   23.3 (17.5--29.0)           7             96.1          \<0.001        998/4844
  Mixed                   28.5 (25.9--31.1)          10             90.1          \<0.001       5072/15921
  Urban                   29.4 (16.6--42.2)           6             99.6          \<0.001       5308/13864
  **Study Year**                                                                             
  1999--2001              11.0 (9.7--12.3)            3             35.9           0.210         371/3385
  2002--2014              24.4 (20.2--28.7)          20             99.2          \<0.001       16427/55713
  **Total**             **22.7 (18.3--27.0)**      **23**         **99.3**      **\<0.001**   **16798/59098**

As shown in [Table 2](#pone-0109549-t002){ref-type="table"}, before 1996, rural area (χ^2^ = 48054.05, *p*\<0.001), inland area (χ^2^ = 1479.00, *p*\<0.001), high altitude (χ^2^ = 52150.24, *p*\<0.001), small study sample size (χ^2^ = 255.52, *p*\<0.001), location in West China (χ^2^ = 2023.41, *p*\<0.001), and both low and high levels of iodine intake (χ^2^ = 8809.32, *p*\<0.001) might indicate a high prevalence of goiter.

As shown in [Table 3](#pone-0109549-t003){ref-type="table"}, after 1996, subgroups including rural area (χ^2^ = 448.82, *p*\<0.001), diagnosis using ultrasound (χ^2^ = 101.98, *p*\<0.001) and study year 2002--2014 (χ^2^ = 421.05, *p*\<0.001) had a greater prevalence of goiter. Of note, iodine nutrition may also be associated with this greater prevalence. Among the four iodine intake categories, the prevalence of goiter was lowest in the subgroup with adequate iodine, 4.3% (95% CI: 2.6%, 5.9%), and prevalence data for the insufficient subgroup was 23.2% (95% CI: 20.3%, 26.1%) and for excess iodine subgroup was 14.5% (95% CI: 8.8%, 20.1%), both of which were higher (χ^2^ = 190.17, *p*\<0.001).

For TNs, prevalence among subgroups of location and study year was very different ([Table 4](#pone-0109549-t004){ref-type="table"}). Prevalence rates for North, East and West China were 11.0% (95% CI: 9.7%, 12.3%), 25.5% (95% CI: 21.2%, 29.8%) and 18.3% (95% CI: 7.6%, 28.9%) (χ^2^ = 800.56, *p*\<0.001), respectively. In terms of the study year, 11.0% (95% CI: 9.7%, 12.3%) of people investigated between 1999 and 2001 were diagnosed with TNs and this increased to 24.4% (95% CI: 20.2%, 28.7%) after 2002 (χ^2^ = 538.27, *p*\<0.001).

Analysis of Heterogeneity and Publication Bias {#s3d}
----------------------------------------------

We noted a significant overall heterogeneity within the studies (*p*\<0.001, I^2^ = 97.4--100.0%), which decreased through subgroup analyses. Egger\'s test for the three independent research categories revealed no evidence of publication bias (*p* = 0.101, 0.148 and 0.113, respectively).

Discussion {#s4}
==========

We examined 52 epidemiological research studies covering 14 provinces, municipalities and autonomous regions in China. We systematically analyzed the prevalence of goiter and TNs prior to and after 1996, when China implemented the USI program. To our knowledge this is one of the first studies of this kind.

Research indicates that the prevalence of goiter in children 8--10 years-of-age is an indicator of local iodine consumption [@pone.0109549-World1]. Our analysis, however, focused on the general population, to provide epidemiological information concerning the disease itself. Iodine nutrition is certainly an important factor for goiter, and the association between iodine intake and goiter prevalence has been investigated extensively.

Indian researchers reported that the prevalence of goiter was 65.9% in an iodine-deficient area [@pone.0109549-Pandav1], which decreased to 27.7% two decades after the USI program [@pone.0109549-Yadav1]. In Denmark, the goiter prevalence was 13.4% in an area with mild iodine deficiency and 19.7% in an area with moderate iodine deficiency, indicating that even a modest increase in iodine intake might significantly reduce IDDs [@pone.0109549-Knudsen1]. In China, the USI program was launched in 1996 to prevent IDDs, establishing an important time boundary for our study. We observed a trend similar to the study in India. The overall goiter prevalence was 22.8% prior to 1996 and this was halved (declined to 12.6%). Thus, the USI program might be beneficial in China.

Also, iodine excess may increase thyroid volume [@pone.0109549-World1]. In our subgroup analyses, both before and after 1996, the prevalence of goiter significantly changed with iodine status, with data suggesting hormesis---emphasizing that overdoses of iodine, as well as deficiencies may be associated with high prevalence of goiter. Meanwhile, previous studies suggest a goitrogenic effect of excess iodine in school-age children and adults [@pone.0109549-Zhao2]--[@pone.0109549-Yu3]. In areas with high iodine content in the drinking water, school-age children had elevated median UIC and endemic goiter, suggesting that, in addition to adjusting the iodine content of salt, improving water quality is also necessary [@pone.0109549-Zhao2], [@pone.0109549-Liu4]. In a prospective study, 10 normal men accepted daily oral intake of excess iodine for 1 month. At the end of this treatment, their mean thyroid volume increased, which eventually returned to baseline within 4 weeks after iodine withdrawal [@pone.0109549-Namba1]. LeMar reported that excess iodine from tetraglycine hydroperiodide tablets caused a reversible thyroid stimulating hormone (TSH)-dependent thyroid enlargement [@pone.0109549-LeMar1]. For Peace Corps volunteers, after the removal of excess iodine from water, the mean serum iodine declined sharply, and the goiter rate fell from 44 to 30% [@pone.0109549-Pearce1]. In animal models, excessive iodine intake has been shown to lead to thyroid enlargement [@pone.0109549-Yu3]. Thus, iodine excess should be scrutinized. In agreement with this concern, we observed that after 1996, the pooled goiter prevalence increased from 10.7% before 2002 to 25.1% afterwards, indicating an impending problem.

We also observed that altitude correlated with goiter: the plateau environment was associated with higher goiter frequency than residence in the plains and hills, a finding similar to trends in previous surveys that may be explained by deficiencies in natural iodine at high altitudes and limited educational and economic support for the people who reside there [@pone.0109549-Harris1]--[@pone.0109549-AbuEshy1].

There is a longstanding controversy regarding the relationship between the prevalence of TNs and iodine nutrition because of the varied epidemiological situation across the globe. Among a Swedish population with adequate iodine, the rate of TNs was only 2.6% [@pone.0109549-Takahashi1]. German data from a previously iodine deficient area revealed a 20.2% prevalence of TNs, with a smaller rate for men [@pone.0109549-Vlzke1]. Mexico, which formerly was mildly iodine deficient, now consumes more than normal iodine intake and here the locally-identified TNs frequency was 19.6% [@pone.0109549-HurtadoLopez1]. Overall, the prevalence of TNs in mainland China was similar to that of other countries and regions of historic iodine deficiency and present states of iodine sufficiency. In addition, our data indicate that the prevalence of TNs after 2002 was higher than the rate prior to 2002---11.0% of those investigated from 1999--2001 were diagnosed with TNs, and this increased to 24.4% between 2002 and 2014.

Unlike goiter, which has a strong etiological relationship with iodine nutrition, the prevalence of TNs also depends on sex, age and head-and-neck radiation exposure history [@pone.0109549-Rojeski1], [@pone.0109549-Gharib2]. According to the present information, TNs are more common in cities than in the country, which may be explained by lifestyle choices [@pone.0109549-Leng1], [@pone.0109549-Wang3]. Furthermore, females were at greater risk for TNs and this difference was not changed when females were further divided into rural, mixed and urban groups.

In conclusion, we report that the USI program in China successfully reduced the prevalence of goiter after 1996. However, the program might cause excesses iodine intake that may be associated with a high prevalence of goiter. The prevalence of TNs also increased over time. Also, 5% of TNs may be malignant [@pone.0109549-American1], so an increased prevalence of TNs might predict more thyroid carcinoma patients. In view of this information, in 2012, China adjusted the iodized salt concentration to 20--30 mg/kg (previously 35 mg/kg) and provincial governments and health administrative departments were allowed to formulate local standards within ±30% of recommended concentrations based on data for their area [@pone.0109549-Ministry2], [@pone.0109549-Meng1].

Our study has several limitations. First, variations in the quality of the selected papers exist. Uncertain data will confound investigations into potential influences on heterogeneity. Secondly, primary TNs articles did not use a completely unified diagnostic criterion, but they did diagnose with ultrasound. Third, data from qualified articles failed to cover most of mainland China provinces. Still, we included all available information about goiter and TNs from the past three decades and this report is the first to document the epidemiological status of both diseases before and after the USI program in mainland China. In addition, our work underscores the need for additional population-based studies in areas excluded from this analysis.

Our data show that the implementation of USI program is beneficial but may pose iodine risks; therefore, salt iodization standards should be set according to local conditions. Also, some epidemiology studies remain to be undertaken, and these are essential for comprehensive original data on the epidemiology and distribution of thyroid diseases. Our future work will include a national baseline study on thyroid diseases which will be implemented from 2014 to 2016 and these data will provide broad and accurate information for other researchers.
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